PT-141 Explained: Benefits, Side Effects, and Human Evidence
Metabolism Explained · Evidence checked October 12, 2026 PT-141, also called bremelanotide, is a peptide medicine that activates melanocortin receptors. Its prescription form, Vyleesi, is approved for a specific low-desire disorder in premenopausal women. Benefits average out to a modest improvement over placebo, and nausea is common. Human studies in men show an erectile response, … Read more